About Us
Research Watch
स्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छनेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकटFrontline Perspectives on Nursing Leadership in NepalProtecting the Smallest Lungs from the Hidden Grip of RSV in KathmanduThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERsस्क्रिनमा देखिने चुरोट: सुर्तीजन्य हानि न्यूनीकरण नीतिमा दक्षिण एसियाले अझै के छुटाइरहेको छनेपालमा पिसाब नलीको संक्रमण र एन्टिबायोटिक प्रतिरोधको बढ्दो संकटFrontline Perspectives on Nursing Leadership in NepalProtecting the Smallest Lungs from the Hidden Grip of RSV in KathmanduThe Heavy Burden of Bullying on Student Wellbeing in NepalThe Emerging Landscape of Thyroid Health in Central NepalHow a Recent Western Nepal Study is Redefining Anemia DiagnosisHow H. Pylori is Impacting the Health of Karnali’s High-Altitude CommunitiesSweet Poison, Bitter Reality: The Unseen Diabetes Epidemic Among Nepal’s YouthHow Missing Checklists and Protocols are Costing Lives in Nepal’s ERs

Measuring what matters: evaluating the psychometric properties of goal attainment scaling in a psychosocial dementia trial.

Researchers

Jessica Budgett, Harriet Demnitz-King, Andrew Sommerlad, Nuriye Kupeli, Victoria Vickerstaff, Claudia Cooper

Abstract

It can be challenging to identify clinically meaningful, responsive primary outcomes for psychosocial intervention trials in people with dementia. Goal Attainment Scaling (GAS), a personalised, patient-generated outcome measure, enables individuals to define and evaluate progress toward meaningful goals. Evidence regarding its psychometric properties in dementia trials, however, remains limited. To evaluate the feasibility, reliability, and validity of GAS within the randomised controlled trial of NIDUS-Family (New Interventions in Dementia Study), a goal-based psychosocial intervention. 302 people with dementia and family carer dyads collaboratively set baseline goals toward supporting the person with dementia to live well at home. In a psychometric evaluation guided by the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) framework, we examined follow-up completion (measuring feasibility); rater agreement; intra-rater reliability; construct validity by assessing correlations between change in GAS and quality-of-life (DEMQOL-proxy and CarerQoL); and predictive validity by testing whether GAS change predicted living at home at 12 months. GAS completion rates were 86% at 6 months and 82% at 12 months. GAS demonstrated excellent inter-rater (Intraclass Correlation Coefficient = 0.99) and intra-rater reliability (Cohen's kappa = 0.91). There were significant but weak positive correlations between GAS change and carer and person with dementia quality-of-life (r = 0.14-0.22). GAS change was associated with remaining at home (odds ratio 1.08 per point increase; P <.01). GAS is feasible, valid and reliable, so may be a sensitive and clinically meaningful candidate primary outcome for psychosocial dementia trials. Correlations with global quality of life were significant but modest, consistent with GAS capturing personalised rather than generic outcomes.
Source: PubMed (PMID: 42735391)View Original on PubMed